Craneware (CRW)

Sector:

Health Care

Index:

FTSE AIM 100

2,300.00p
   
  • Change Today:
      20.00p
  • 52 Week High: 2,380.00
  • 52 Week Low: 1,320.00
  • Currency: UK Pounds
  • Shares Issued: 35.32m
  • Volume: 114,400
  • Market Cap: £812.38m
  • RiskGrade: 185

Craneware reports on year of growth

By Josh White

Date: Tuesday 06 Sep 2016

LONDON (ShareCast) - (ShareCast News) - Provider of 'value cycle' solutions to the US healthcare market, Craneware, announced its results for the year ended 30 June on Tuesday, with the total contract value in the year reaching record levels of $82.3m, up from $72.9m a year earlier.
The AIM-traded firm said new sales increased by 63% to $58.6m, with a renewal rate remaining above 100% by dollar value.

Its revenue increased 11% to $49.8m, with adjusted EBITDA improving 10% to $15.9m and profit before tax growing by 10% to $13.9m.

Basic adjusted earnings per share increased 13% to $0.429, and adjusted diluted earnings per share grew to $0.423 from $0.375.

Craneware's continued operating cash conversion remained above 100% of adjusted EBITDA.

It reported cash at year-end of $48.8m, compared with $41.8m in the prior year, and after payment of a $6m dividend to shareholders.

The board proposed a final dividend of 9p, or 12 US cents, per share giving a total dividend for the year of 16.5p, or 22 cents, per share, up from 14p last year, though due to exchange rate fluctuations that was also 22 cents.

"Craneware is in a stronger position than ever and we are passionate about the opportunity ahead," said CEO Keith Neilson.

"The double digit growth in our reported revenue and adjusted EBITDA are only beginning to reflect the record levels of sales which began three years ago.

"Importantly, the investment we are making in our product suite mean our market opportunity is now several times larger than it was when we joined AIM in 2007," he explained.

Neilson said the market was continuing to evolve as anticipated, and US healthcare providers are seeking solutions to address the challenges the new value based reimbursement environment brings to them.

"We believe the investment we are making to expand the products in our Value Cycle suite addresses these challenges and we are now recognised beyond our original niche within the revenue cycle as a more strategic provider within a hospital's financial operations and their value cycle."

"We are confident that the ongoing investment we are making, combined with our continuing sales successes, mean we are well positioned to deliver continued future growth as well as increasing stakeholder value," Neilson commented.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Craneware Market Data

Currency UK Pounds
Share Price 2,300.00p
Change Today 20.00p
% Change 0.88 %
52 Week High 2,380.00
52 Week Low 1,320.00
Volume 114,400
Shares Issued 35.32m
Market Cap £812.38m
RiskGrade 185

Craneware Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.68% below the market average93.68% below the market average93.68% below the market average93.68% below the market average93.68% below the market average
93.75% below the sector average93.75% below the sector average93.75% below the sector average93.75% below the sector average93.75% below the sector average
Price Trend
92.74% above the market average92.74% above the market average92.74% above the market average92.74% above the market average92.74% above the market average
94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average
Income
97.49% below the market average97.49% below the market average97.49% below the market average97.49% below the market average97.49% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average
Growth
19.12% below the market average19.12% below the market average19.12% below the market average19.12% below the market average19.12% below the market average
27.78% below the sector average27.78% below the sector average27.78% below the sector average27.78% below the sector average27.78% below the sector average

What The Brokers Say

Strong Buy 3
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 4
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Craneware Dividends

  Latest Previous
  Interim Final
Ex-Div 21-Mar-24 23-Nov-23
Paid 15-Apr-24 15-Dec-23
Amount 13.00p 16.00p

Trades for 03-May-2024

Time Volume / Share Price
10:38 12,500 @ 2,275.00p
17:07 900 @ 2,300.00p
16:36 7,883 @ 2,303.17p
16:35 3,012 @ 2,300.00p
16:35 69 @ 2,300.00p

Craneware Key Personnel

CEO Keith Neilson

Top of Page